UK’s OptiBiotix Launches Prebiotic Supplement Ingredient For European And African Markets
Dietary supplement manufacturers interested in marketing prebiotics and synbiotics – combinations of pre- and post-biotics – in Europe and Africa now have the option of OptiBiotix's xylo-oligosaccharide prebiotic, OptiXOS, which the firm claims has superior stability and gastrointestinal tolerance.
You may also be interested in...
In this episode, HBW Insight talks probiotics with David Pineda Ereño, founder of DPE International Consulting and consultant to the International Probiotics Association. Since 2006, no health claims for probiotics have been allowed by harmonized European Union regulations. Even the term "probiotic" is considered an unauthorized health claim by the European Commission. However, as Pineda Ereño explains, many EU member states, including Italy and Spain, are starting to go their own way, adopting a more liberal approach to this booming wellness market. We discuss what the future of EU probiotics regulation may hold, as well as some recent exciting scientific developments, pointing to the health benefits of these extremely popular products.
UK probiotics specialist Optibiotix' CEO Stephen O'Hara speaks exclusively to HBW Insight about the firm's growth ambitions, which have not been held back by the coronavirus pandemic.
British probiotic specialist OptiBiotix Health has struck a three-year distribution deal for its CholBiome supplement in Russia and Kazakhstan.